Clinical targets of A2B adenosine receptor antagonists

被引：0
|
作者：
Linden, J
Figler, RA
Jacobson, KA
Wang, GQ
LaNoue, KF
机构：
[1] Univ Virginia, Sch Med, Dept Mol Physiol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Dept Biol Phys, Charlottesville, VA 22908 USA
[3] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA
[4] Adenosine Therapeut LLC, Charlottesville, VA USA
[5] NIH, Bethesda, MD 20892 USA
[6] Penn State Univ, Hershey, PA USA
来源：
DRUG DEVELOPMENT RESEARCH | 2002年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
51
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [21] Do adenosine receptor antagonists have an antidiabetic effect mediated by A2B receptors?
    Rüsing, D
    Müller, CE
    Verspohl, EJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R29 - R29
  • [22] Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor
    Bedford, Simon T.
    Benwell, Karen R.
    Brooks, Teresa
    Chen, Ijen
    Comer, Mike
    Dugdale, Sarah
    Haymes, Tim
    Jordan, Allan M.
    Kennett, Guy A.
    Knight, Anthony R.
    Klenke, Burkhard
    LeStrat, Loic
    Merrett, Angela
    Misra, Anil
    Lightowler, Sean
    Padfield, Anthony
    Poullennec, Karine
    Reece, Mark
    Simmonite, Heather
    Wong, Melanie
    Yule, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5945 - 5949
  • [23] Do adenosine receptor antagonists have an antidiabetic effect mediated by A2B receptors?
    Verspohl, EJ
    Rüsing, D
    Müller, CE
    DIABETOLOGIA, 2005, 48 : A169 - A169
  • [24] Characterization of novel dual A2A/A2B adenosine receptor antagonists for cancer immunotherapy
    Galezowski, Michal
    Wegrzyn, Paulina
    Bobowska, Aneta
    Commandeur, Claude
    Dziedzic, Katarzyna
    Nowogrodzki, Marcin
    Obara, Alicja
    Szeremeta-Spisak, Joanna
    Dzielak, Anna
    Lozinska, Iwona
    Dudek, Marcelina
    Janiga, Anita
    Reus, Jacek
    Wronowski, Marek
    Swirski, Mateusz
    Radzimierski, Adam
    Ziembik, Magdalena
    Mierzwicka, Joanna
    Wojcik-Jaszczynska, Katarzyna
    Gocek, Elzbieta
    Grycuk, Karolina
    Golas, Aniela
    Pierzchala, Olga
    Zachmann, Julian
    Nowak, Mateusz
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Molecular Modeling and molecular dynamics simulation of the human A2B adenosine receptor.: The study of the possible binding modes of the A2B receptor antagonists
    Ivanov, AA
    Baskin, II
    Palyulin, VA
    Piccagli, L
    Baraldi, PG
    Zefirov, NS
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) : 6813 - 6820
  • [26] A2B adenosine receptor signaling and regulation
    Gao, Zhan-Guo
    Haddad, Mansour
    Jacobson, Kenneth A.
    PURINERGIC SIGNALLING, 2024,
  • [27] Ligands for A2B adenosine receptor subtype
    Baraldi, Pier Giovanni
    Romagnoli, Romeo
    Preti, Delia
    Fruttarolo, Francesca
    Carrion, Maria Dora
    Tabrizi, Mojgan Aghazadeh
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (28) : 3467 - 3482
  • [28] The resurgence of A2B adenosine receptor signaling
    Aherne, Carol M.
    Kewley, Emily M.
    Eltzschig, Holger K.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2011, 1808 (05): : 1329 - 1339
  • [29] Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy
    A. Kalhan
    B. Gharibi
    M. Vazquez
    B. Jasani
    J. Neal
    M. Kidd
    I. M. Modlin
    R. Pfragner
    D. A. Rees
    J. Ham
    Purinergic Signalling, 2012, 8 : 265 - 274
  • [30] Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy
    Kalhan, A.
    Gharibi, B.
    Vazquez, M.
    Jasani, B.
    Neal, J.
    Kidd, M.
    Modlin, I. M.
    Pfragner, R.
    Rees, D. A.
    Ham, J.
    PURINERGIC SIGNALLING, 2012, 8 (02) : 265 - 274
12345